Active Ingredient: ROFLUMILAST
Proprietary Name: DALIRESP
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 500MCG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N022522
Product Number: 001
Approval Date: Feb 28, 2011
Applicant Holder Full Name: ASTRAZENECA PHARMACEUTICALS LP
Marketing Status:
Prescription
Patent and Exclusivity Information
